Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting.
Saved in:
| Title: | Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting. |
|---|---|
| Authors: | Almenoff JS; GlaxoSmithKline, Global Clinical Safety and Pharmacovigilance, Five Moore Drive, PO Box 13398, 5.4214.4C, Research Triangle Park, NC 27709-3398, USA. june.s.almenoff@gsk.com, DuMouchel W, Kindman LA, Yang X, Fram D |
| Source: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2003 Sep; Vol. 12 (6), pp. 517-21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Print ISSN: 1053-8569 (Print) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
